Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer.
about
The Patient Protection and Affordable Care Act and reproductive health: harnessing data to improve careNew Insights on Glucosylceramide Synthase in Cancer Drug Resistance and Myelosuppression.Evaluation of prevalent and incident ovarian cancer co-morbidity.The opposite effects of doxorubicin on bone marrow stem cells versus breast cancer stem cells depend on glucosylceramide synthaseDefined lipid analogues induce transient channels to facilitate drug-membrane traversal and circumvent cancer therapy resistanceAdjuvant chemotherapy in elderly patients with breast cancer: key challenges.Acute and subchronic toxicity of the antitumor agent rhodium (II) citrate in Balb/c mice after intraperitoneal administration.The use of nanoparticulates to treat breast cancer.Combination breast cancer chemotherapy with doxorubicin and cyclophosphamide damages bone and bone marrow in a female rat model.Assessment of chemotherapy on various biochemical markers in breast cancer patients.Long Chain Omega-3 Polyunsaturated Fatty Acid Supplementation Protects Against Adriamycin and Cyclophosphamide Chemotherapy-Induced Bone Marrow Damage in Female Rats.Combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil causes trabecular bone loss, bone marrow cell depletion and marrow adiposity in female rats.
P2860
Q26861401-7C92DA79-B8B3-4497-A7C1-5E23580556AFQ34499844-2F7EEE3B-8B35-4BE7-B73B-FB2FB459A02DQ35999577-5E93169A-2529-4909-B400-2F6E4275D5EFQ36269159-E16FD556-2D25-46A9-BD3F-AC0E31A8CBD5Q36907239-C80A4175-EDFC-4284-954B-AF184C7D1E2CQ38787215-7E53DE9A-E7F5-4E90-A97B-8AFA0F42E3A0Q41680103-38E68F73-5718-42EE-8A0F-D77DC05CB294Q45066468-BF8D577A-DEEA-420E-BA7C-E28027CC1D18Q47750908-B8142B0F-89B9-4D83-B149-930829E0B5E4Q48335444-13ED7C64-ACBD-4B2A-82EC-6E84B5D93DCFQ50131910-10ACD016-46AD-4730-8BAD-B7349234021FQ51017929-6329AF4B-E90C-4376-9C6F-7BCC0B0F58DA
P2860
Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Chemotherapy use and risk of b ...... ith breast and ovarian cancer.
@ast
Chemotherapy use and risk of b ...... ith breast and ovarian cancer.
@en
type
label
Chemotherapy use and risk of b ...... ith breast and ovarian cancer.
@ast
Chemotherapy use and risk of b ...... ith breast and ovarian cancer.
@en
prefLabel
Chemotherapy use and risk of b ...... ith breast and ovarian cancer.
@ast
Chemotherapy use and risk of b ...... ith breast and ovarian cancer.
@en
P2093
P2860
P1433
P1476
Chemotherapy use and risk of b ...... ith breast and ovarian cancer.
@en
P2093
Chih-Chin Liu
Xianglin L Du
Zhannat Nurgalieva
P2860
P2888
P304
P356
10.1007/S12032-010-9512-5
P577
2010-04-02T00:00:00Z
P6179
1038896024